33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.61%
Revenue growth below 50% of BRZE's 3.44%. Michael Burry would check for competitive disadvantage risks.
-0.58%
Cost reduction while BRZE shows 3.62% growth. Joel Greenblatt would examine competitive advantage.
2.34%
Gross profit growth 50-75% of BRZE's 3.35%. Martin Whitman would scrutinize competitive position.
0.72%
Margin expansion while BRZE shows decline. John Neff would investigate competitive advantages.
-0.62%
R&D reduction while BRZE shows 10.47% growth. Joel Greenblatt would examine competitive risk.
4.59%
G&A growth above 1.5x BRZE's 2.68%. Michael Burry would check for operational inefficiency.
10.85%
Similar marketing expense growth to BRZE's 10.75%. Walter Schloss would investigate industry requirements.
No Data
No Data available this quarter, please select a different quarter.
6.31%
Operating expenses growth 50-75% of BRZE's 10.18%. Bruce Berkowitz would examine efficiency.
4.87%
Total costs growth 50-75% of BRZE's 8.44%. Bruce Berkowitz would examine efficiency.
-100.00%
Interest expense reduction while BRZE shows 0.00% growth. Joel Greenblatt would examine advantage.
-2.57%
D&A reduction while BRZE shows 16.96% growth. Joel Greenblatt would examine efficiency.
52.06%
EBITDA growth while BRZE declines. John Neff would investigate advantages.
52.82%
EBITDA margin growth while BRZE declines. John Neff would investigate advantages.
-21.46%
Both companies show declining income. Martin Whitman would check industry conditions.
-19.53%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-12.09%
Other expenses reduction while BRZE shows 18.76% growth. Joel Greenblatt would examine advantage.
49.87%
Pre-tax income growth while BRZE declines. John Neff would investigate advantages.
50.66%
Pre-tax margin growth while BRZE declines. John Neff would investigate advantages.
-79.57%
Tax expense reduction while BRZE shows 24.88% growth. Joel Greenblatt would examine advantage.
50.35%
Net income growth while BRZE declines. John Neff would investigate advantages.
51.14%
Net margin growth while BRZE declines. John Neff would investigate advantages.
52.38%
EPS growth while BRZE declines. John Neff would investigate advantages.
52.38%
Diluted EPS growth while BRZE declines. John Neff would investigate advantages.
0.99%
Share count reduction exceeding 1.5x BRZE's 2.26%. David Dodd would verify capital allocation.
0.99%
Diluted share reduction exceeding 1.5x BRZE's 2.26%. David Dodd would verify capital allocation.